Aditxt Inc is a biotech company focused on enhancing the immune system through innovative technologies designed to promote immune tolerance. The company seeks to develop therapies that can help manage and treat immune-related diseases by leveraging its proprietary platform to create customized solutions. Aditxt's research and development efforts aim to address a range of immunological disorders, potentially transforming the landscape of immunotherapy and improving patient outcomes through better immune system management. Read More
After years of incremental updates across major social media platforms, Myseum, Inc. (NASDAQ: MYSE) is introducing what many see as a rare breakthrough in social media innovation with the launch of Picture Party by Myseum, a new privacy-first social networking platform designed for real-world sharing.
Curious to know what's happening on the US markets in the middle of the day on Wednesday? Join us as we explore the top gainers and losers in today's session.
Wondering how the US markets performed one hour before the close of the markets on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.
Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.
As the regular session of the US market concludes on Friday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
As we await the opening of the US market on Friday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
After the conclusion of the US market's regular session on Wednesday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Aditxt (NASDAQ: ADTX), a social innovation platform accelerating health-focused technologies, detailed its bitXbio strategy, a framework connecting public markets, blockchain and Web3, and digital asset treasuries to support breakthrough health innovations through a participation-driven model. The Company filed a Preliminary Proxy Statement seeking shareholder approval for several proposals, including an Employee Stock Purchase Plan and a non-binding advisory vote to amend its Certificate of Incorporation to change its name to bitXbio, Inc., reflecting a planned evolution into a platform linking digital assets with life sciences ventures. Aditxt said the ESPP is intended to strengthen employee-shareholder alignment and support its long-term growth vision.
Aditxt, Inc. (Nasdaq: ADTX) (“Aditxt” or the “Company”), a social innovation platform accelerating promising health innovations, today shared its growth vision under the bitXbio™ strategy. bitXbio™ (pronounced “bit-by-bio”) is a transformational framework designed to connect public markets, blockchain and Web3, and digital asset treasuries for advancing breakthrough health innovations. The bitXbio™ strategy is intended to scale Aditxt as a social innovation platform representing a global community of shareholders and contributors engaged through a participation-driven model that supports the advancement of health-focused ventures and partnerships.
Stay up-to-date with the latest market trends in the middle of the day on Thursday. Explore the top gainers and losers during today's session in our detailed report.
The US market is yet to commence its session on Thursday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Aditxt (NASDAQ: ADTX), a social innovation platform accelerating promising health innovations, will implement a 1-for-113 reverse stock split of its common stock effective at the opening of trading on Nov. 3, 2025. The stock will continue trading under the symbol ADTX. Following the split, every 113 shares of issued and outstanding common stock will convert into one share, rounding up fractional shares. The move, approved by stockholders on Sept. 23, 2025, is intended to help the Company regain compliance with Nasdaq’s minimum bid price requirement.
